Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis
出版年份 2022 全文链接
标题
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis
作者
关键词
-
出版物
JAMA Neurology
Volume -, Issue -, Pages -
出版商
American Medical Association (AMA)
发表日期
2022-07-25
DOI
10.1001/jamaneurol.2022.1929
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
- (2020) Anna He et al. LANCET NEUROLOGY
- Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis
- (2020) Nathaniel Lizak et al. JAMA Neurology
- Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis
- (2020) Maria Pia Amato et al. BRAIN
- Delay from treatment start to full effect of immunotherapies for multiple sclerosis
- (2020) Izanne Roos et al. BRAIN
- Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis
- (2019) Yvonne Naegelin et al. JAMA Neurology
- Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis
- (2019) Dalia Rotstein et al. Nature Reviews Neurology
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis
- (2018) Marita Zimmermann et al. CNS DRUGS
- Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis
- (2018) Jordana Hughes et al. JAMA Neurology
- The Italian multiple sclerosis register
- (2018) Maria Trojano et al. NEUROLOGICAL SCIENCES
- Progressive MS trials: Lessons learned
- (2017) Carmen Tur et al. Multiple Sclerosis Journal
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progressive MS trials: Lessons learned
- (2017) Carmen Tur et al. Multiple Sclerosis Journal
- Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses
- (2017) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Unknown
- (2016) ANNALS OF NEUROLOGY
- Unknown
- (2016) ANNALS OF NEUROLOGY
- Relapses and disability accumulation in progressive multiple sclerosis
- (2014) M. M. Paz Soldan et al. NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Natalizumab reduces relapse clinical severity and improves relapse recovery in MS
- (2014) Fred D. Lublin et al. Multiple Sclerosis and Related Disorders
- Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing
- (2013) Lauren Strober et al. Multiple Sclerosis Journal
- Interferon Beta-1b for the Treatment of Primary Progressive Multiple Sclerosis
- (2011) Carmen Tur ARCHIVES OF NEUROLOGY
- A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
- (2009) X. Montalban et al. Multiple Sclerosis Journal
- Impact of multiple sclerosis relapses on progression diminishes with time
- (2009) H. Tremlett et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started